PHVS (Pharvaris N.V.) Pangali Forward P/E
Reliance on orphan drug status guarantees Pharvaris N.V. (PHVS) exclusive marketing rights. The company aims to dominate the treatment of angioedema by replacing injections with convenient deucrictibant tablets. The company's forward P/E history confirms this trajectory, with the current metric standing at 0.00. Meanwhile, the R&D center is completing a critical trial phase for breakthrough agents designed for the prevention of angioedema.
Rincian analitis perusahaan Pharvaris N.V.
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Pharvaris N.V.|PHVS - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Pharvaris Corp|PHVS - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Pharvaris NV|PHVS - Utang jangka dawa|Utang jangka cendhak perusahaan Pharvaris|Rasio cepet pharvaris.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
PHVS - Bathi pungkasan|Proyeksi bathi mangsa ngarep Pharvaris N.V.|PHVS - Pangali P/E|Rega marang bathi mangsa ngarep Pharvaris N.V.|PHVS - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Pharvaris Pharma|PHVS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Pharvaris|PHVS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan pharvaris.com|PHVS - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Pharvaris N.V.
- data total pendapatan lan volume dodolan:
Ringkesan analitik perusahaan:pharvaris.com
High drug development costs leave the biotech sector vulnerable to market volatility; however, patent protection and the complexity of molecule synthesis at Pharvaris N.V. (PHVS) create significant barriers to entry for competitors. The ratio of market price to projected forward earnings allows for an assessment of the premium paid for this potential. By analyzing the company's current forward P/E ratio, an investor can determine the fairness of the valuation regarding expected earnings, where low values signal that the asset is undervalued.
Pesaing Pharvaris N.V. (PHVS)
Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Dianthus Pharma (DNTH) - Rasio prakiraan rega marang bathi|AbCellera Biologics - Pangali Forward P/E|tourmalinebio.com - Rasio kapitalisasi marang bathi mangsa ngarep|Precigen (PGEN) - Rega marang bathi mangsa ngarep|Pharming Group - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc|UPB (Upstream Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ZBIO|Pangali Forward P/E immunome.com (IMNM)|Pangali Forward P/E GOSS (gossamerbio.com)|Kapitalisasi marang proyeksi bathi KalVista Pharma (KALV)|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi
